文献速递角膜与眼表疾病

泪腺功能恢复的研究进展

Advances in Functional Restoration of the Lacrimal Glands.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

泪腺功能障碍是干眼病特征,可致眼部不适、视觉障碍甚至视力丧失。本文综述近年生物工程进展,包括祖细胞注射、三维组织工程、直接重编程、医疗器械刺激泪液分泌及生物杂合支架等策略,旨在功能恢复泪腺作为未来干眼治疗。

要点

  • 祖细胞注射疗法在修复泪腺组织方面显示潜力。
  • 三维组织工程通过再现上皮-间质相互作用再生分泌腺结构。
  • 直接重编程方法可从人多能干细胞诱导泪腺发育标志物。

核心结论

  • 生物工程与再生医学进展为泪腺功能恢复提供了新型策略,有望成为未来干眼治疗方向。

研究设计与样本

  • 综述文章,总结近年泪腺再生相关的生物工程进展,未报告系统检索范围或样本量。

主要发现

  • 祖细胞注射疗法在修复泪腺组织方面显示潜力。
  • 当前三维组织工程技术通过在体外和体内再现个体发育中的上皮-间质相互作用,再生分泌腺结构。
  • 新型直接重编程方法提示可从人多能干细胞诱导泪腺发育过程中的标志物。
  • 工程科学提出了刺激泪液分泌的医疗器械和重建三维泪腺结构的生物杂合支架。

关键数值与推荐

  • 传统疗法包括人工泪液、泪液替代物(如自体血清滴眼液)和唾液腺移植。
  • 再生医学方法被确定为恢复泪腺功能的新型策略。

临床怎么用

  • 在传统治疗基础上,关注再生医学策略作为泪腺功能恢复的潜在新途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The lacrimal glands produce tears to support a healthy homeostatic environment on the ocular surface. The lacrimal gland dysfunction characteristic of dry eye disease causes ocular discomfort and visual disturbances and in severe cases can result in a loss of vision. The demand for adequate restoration of lacrimal gland function has been intensified due to advances in stem cell biology, developmental biology, and bioengineering technologies. In addition to conventional therapies, including artificial tears, tear alternatives (such as autologous serum eye drops) and salivary gland transplantation, a regenerative medicine approach has been identified as a novel strategy to restore the function of the lacrimal gland. Recent studies have demonstrated the potential of progenitor cell injection therapy to repair the tissue of the lacrimal glands. A current three-dimensional (3D) tissue engineering technique has been shown to regenerate a secretory gland structure by reproducing reciprocal epithelial-mesenchymal interactions during ontogenesis in vitro and in vivo. A novel direct reprogramming method has suggested a possibility to induce markers in the lacrimal gland developmental process from human pluripotent stem cells. The development of this method is supported by advances in our understanding of gene expression and regulatory networks involved in the development and differentiation of the lacrimal glands. Engineering science has proposed a medical device to stimulate tearing and a bio-hybrid scaffold to reconstruct the 3D lacrimal gland structure. In this review, we will summarize recent bioengineering advances in lacrimal gland regeneration toward the functional restoration of the lacrimal glands as a future dry eye therapy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hirayama M. Advances in Functional Restoration of the Lacrimal Glands. Invest Ophthalmol Vis Sci. 2018. PMID: 30481824. doi:10.1167/iovs.17-23528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。